Crossref

1. Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis

- Abdolhalim Rajabi

- Heidar Sharafi

- Seyed Moayed Alavian

2. Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis

- Fardin Dolatimehr

- Hamidreza Karimi-Sari

- Mohammad Saeid Rezaee-Zavareh

- Seyed Moayed Alavian

- Bita Behnava

- Mohammad Gholami-Fesharaki

- Heidar Sharafi

3. Hepatitis Awareness Bus: A Model for Finding Unknown Hepatitis B and C Infections

- Masood Ziaee

- Morteza Hajihosseini

4. Occult Hepatitis B Infection in Hepatitis C Patients with Hematological Disorders

- Nematollah Jonaidi-Jafari

- Mohammad Saeid Rezaee-Zavareh

- Javad Tavallaei-Nosratabadi

- Reza Ajudani

- Mahdi Ramezani-Binabaj

- Hamidreza Karimi-Sari

- Morteza Izadi

- Reza Ranjbar

- Seyyed Mohammad Miri

- Seyed Moayed Alavian

5. The Role of Polymorphisms Near IFNL3 Gene as Predictors of Residual HCV RNA in Buffy Coat after Successful Antiviral Therapy

- Seyyed Mohammad Miri

- Heidar Sharafi

- Ali Pouryasin

- Bita Behnava

- Maryam Keshvari

- Shima Salimi

- Pegah Karimi Elizee

- Seyed Moayed Alavian

6.

7. Hepatitis B and Hepatitis C in Patients with Inherited Disorders of Hemoglobin in Sistan and Baluchistan Province, Iran

- Soheila Khosravi

- Heidar Sharafi

- Esmaeil Sanei Moghadam

- Fariba Heidari

- Mahmod Naibzadeh

- Seyed Moayed Alavian

8. Chronic Hemodialysis Patients; Special Group for Hepatitis C Elimination Programs in Iran

- Hamidreza Karimi-Sari

- Seyed Moayed Alavian

9. Prevalence of Occult HCV Infection in Hemodialysis and Kidney-Transplanted Patients: A Systematic Review

- Fardin Dolatimehr

- Mohammad Hossein Khosravi

- Mohammad Saeid Rezaee-Zavareh

- Seyed Moayed Alavian

10. Letter: the efficacy of interferon‐free regimens in HCV‐related Child C cirrhosis needs careful interpretation

- M. S. Rezaee‐Zavareh

- S. M. Alavian

11. Update on Recommendations for the Clinical Management of Hepatitis C in Iran 2017

- Seyed Moayed Alavian

- Heidar Sharafi

12. Molecular Epidemiology of Kaposi’s Sarcoma-Associated Herpes Virus, and Risk Factors in HIV-infected Patients in Tehran, 2014

- Khashayar Hesamizadeh

- Hossein Keyvani

- Farah Bokharaei-Salim

- Seyed Hamidreza Monavari

- Maryam Esghaei

- Fatemeh Jahanbakhsh Sefidi

13. Development of robust genotype 1a hepatitis C replicons harboring adaptive mutations for facilitating the antiviral drug discovery and study of virus replication

- Hui-Mei Lin

- Pei-Shan Wu

- Han-Shu Hu

- Wan-Chun Chang

- Ren-Huang Wu

- Jia-Ni Tian

- Jyh-Haur Chern

- Andrew Yueh

14.

15. Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBank

- Heidar Sharafi

- Saman Ghalamkari

- Alireza Hassanshahi

- Seyed Moayed Alavian

16. Update on the Prevalence of Hepatitis C Virus Infection Among Iranian General Population: A Systematic Review and Meta-Analysis

- Babak Mirminachi

- Zahra Mohammadi

- Shahin Merat

- Afarin Neishabouri

- Amir Houshang Sharifi

- Seyed Hoda Alavian

- Hosein Poustchi

- Reza Malekzadeh

17. Controversies in the Screening of Hepatitis C Virus Among First-Degree Family Members of the Affected Patients

- Parivash Davoodian

- Hamidreza Mahboobi

18. Assessment of Hepatitis C Virus RNA in Peripheral Blood Mononuclear Cells as a Predictor of Response to Pegylated-Interferon and Ribavirin: A Cohort Study

- Seyyed Mohammad Miri

- Heidar Sharafi

- Shima Salimi

- Farah Bokharaei-Salim

- Bita Behnava

- Maryam Keshvari

- Pegah Karimi Elizee

- Hosein Keyvani

- Seyed Moayed Alavian

19. Public Awareness Campaign and Knowledge of Iranian (Bio)Medical Students Regarding Hepatitis B and C Infections

- Hamidreza Karimi-Sari

- Maryam Tajik

- Mohammad Ehsan Bayatpoor

- Heidar Sharafi

- Seyed Moayed Alavian

20. Elimination and Control of Viral Hepatitis B and C Infections Possible With Greater Attention to High Risk Groups

- Seyed Moayed Alavian

21. Individual-level key associations and modes of exposure for hepatitis C virus infection in the Middle East and North Africa: a systematic synthesis

- Sarwat Mahmud

- Silva P. Kouyoumjian

- Zaina Al Kanaani

- Hiam Chemaitelly

- Laith J. Abu-Raddad

22. Trends in the Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Iranian Patients with Hereditary Bleeding Disorders

- Azar Gharoonpour

- Saeideh Maleki

- Hamid Sharifi

- Seyedehsara Osia

- Heidar Sharafi

- Maryam Keshvari

23. Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?

- Heidar Sharafi

- Seyed Moayed Alavian

24. Comment on Nuño Solinís R, et al. “Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence”

- Patrice Cacoub

25. An update on hepatitis C virus genotype distribution in Jordan: a 12-year retrospective study from a tertiary care teaching hospital in Amman

- Malik Sallam

- Rawan Batarseh

- Anas Natsheh

- Jumana Abbadi

- Esraa Al-Fraihat

- Alaa’ Yaseen

- Doaa Kaddomi

- Nadia Khamees

- Azmi Mahafzah

- Gülşen Özkaya Şahin

26. The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-Analysis

- Hossein Ghaderi-Zefrehi

- Mohammad Gholami-Fesharaki

- Heidar Sharafi

- Farzin Sadeghi

- Seyed Moayed Alavian

27. Treatment of HCV Infection with Direct-Acting Antiviral Agents in Patients with HIV/HCV Co-Infection: A Systematic Review

- Saman Mohazzab-Torabi

- Fardin Dolatimehr

- Heidar Sharafi

- Mahdi Safi-Abadi

- Mohammad Saeid Rezaee-Zavareh

- Ehsan Bayatpour

- Hamidreza Karimi-Sari

- Seyed Moayed Alavian

28. Awareness Campaign in (bio)Medical Students in Iran: a model for increasing the knowledge regarding hepatitis B and C

- H. Karimi-Sari

- M.E. Bayatpoor

- S.M. Alavian

29. An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study

- Ali Mirzazadeh

- Samira Hosseini-Hooshyar

- Armita Shahesmaeili

- Heidar Sharafi

- Mohammad Shafiei

- Jasem Zarei

- Ghazal Mousavian

- Fatemeh Tavakoli

- Nima Ghalekhani

- Mostafa Shokoohi

- Mehrdad Khezri

- Soheil Mehmandoost

- Mohammad Reza Shojaei

- Mohammad Karamouzian

- Alya Briceno

- Meghan D. Morris

- Seyed Moayed Alavian

- Ali-Akbar Haghdoost

- Hamid Sharifi

- Kimberly A. Page

30. Treatment of Hepatitis C Infection with Direct-Acting Antiviral Agents in Liver-Transplant Patients: A Systematic Review and Meta-Analysis

- Mohammad Saeid Rezaee-Zavareh

- Khashayar Hesamizadeh

- Heidar Sharafi

- Seyed Moayed Alavian

31. Aflatoxin B1 exposure and the risk of hepatocellular carcinoma in Iranian carriers of viral hepatitis B and C

- Nasim Habibi

- Mohsen Nassiri-Toosi

- Heidar Sharafi

- Seyed Moayed Alavian

- Masoomeh Shams-Ghahfarokhi

- Mehdi Razzaghi-Abyaneh

32. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting

- Heidar Sharafi

- Hossein Poustchi

- Fatemeh Azimian

- Babak Tamadoni

- Rashid Ramezani

- Mohamad Mehdi Gouya

- Mahdi Sheikh

- Farnaz Hashemi

- Mehrzad Tashakorian

- Ramin Alasvand

- Seyed Moayed Alavian

- Shahin Merat

33. Molecular Tracing of Hepatitis C Virus Genotype 1 Isolates in Iran: A NS5B Phylogenetic Analysis with Systematic Review

- Khashayar Hesamizadeh

- Seyed Moayed Alavian

- Azar Najafi Tireh Shabankareh

- Heidar Sharafi

34. Sofosbuvir and Ribavirin with or Without Pegylated-Interferon in Hepatitis C Virus Genotype-2 or -3 Infections: A Systematic Review and Meta-Analysis

- Mohammad Ehsan Bayatpoor

- Mohammad Hossein Khosravi

- Heidar Sharafi

- Mohammad Saeid Rezaee-Zavareh

- Bita Behnava

- Seyed Moayed Alavian

35. Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C

- Renata Fialho

- Marco Pereira

- Neil Harrison

- Jennifer Rusted

- Richard Whale

36. Methadone Maintenance Therapy (MMT) Clients Should Be More Noticed for Hepatitis C Elimination in Iran

- Hamidreza Karimi-Sari

- Seyed Moayed Alavian

37. Systematic Review and Meta-Analysis of Global Prevalence of HBsAg and HIV and HCV Antibodies among People Who Inject Drugs and Female Sex Workers

- Roya Rashti

- Heidar Sharafi

- Seyed Moayed Alavian

- Yousef Moradi

- Amjad Mohamadi Bolbanabad

- Ghobad Moradi

38. Special Poster Feature: American Association for the Study of Liver Diseases (AASLD): The Liver Meeting® 2016 Coverage

- Chris Ontiveros

39. Impact ofIFNL4rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C

- Maryam Keshvari

- Seyed Moayed Alavian

- Bita Behnava

- Ali Pouryasin

- Johanna C. Craig

- Heidar Sharafi

40. Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline

- Seyed Moayed Alavian

- Behzad Hajarizadeh

- Kamran Bagheri Lankarani

- Heidar Sharafi

- Nasser Ebrahimi Daryani

- Shahin Merat

- Minoo Mohraz

- Masoud Mardani

- Mohamad Reza Fattahi

- Hossein Poustchi

- Mehri Nikbin

- Mahmood Nabavi

- Peyman Adibi

- Masood Ziaee

- Bita Behnava

- Mohammad Saeid Rezaee-Zavareh

- Massimo Colombo

- Hatef Massoumi

- Abdul Rahman Bizri

- Bijan Eghtesad

- Majid Amiri

- Ali Namvar

- Khashayar Hesamizadeh

- Reza Malekzadeh

41. Long-Term Follow-Up of Thalassemia Major Patients with Hepatitis C Virus Treated with Sofosbuvir and Daclatasvir: A Cohort Study

- Fahimeh Safarnezhad Tameshkel

- Mohammad Hadi Karbalaie Niya

- Bahareh Amirkalali

- Nima Motamed

- Jamshid Vafaeimanesh

- Mansooreh Maadi

- Masodreza Sohrabi

- Amir Hossein Faraji

- Mahmoodreza Khoonsari

- Hossein Ajdarkosh

- Mehdi Nikkhah

- Elham Sobh Rakhashankhah

- Farhad Zamani

42. WITHDRAWN: Efficacy and Side Effects of Sofosbuvir and Daclatasvir for Treatment of Hepatitis C in Thalassemia Major Patients with Treatment Experience of Interferon-Based Regimens

- Jamshid Vafaeimanesh

- Fahimeh Safarnezhad Tameshkel

- Hossein Ajdarkosh

- Azita Azarkeyvani

- Mahmoodreza Khoonsari

- Amirhossein Faraji

- Masoudreza Sohrabi

- Sima Aten

- Hossein Keyvani

- Farhad Zamani

43. Efficacy and Safety of Generic Sofosbuvir/Ledipasvir Fixed-Dose Combination in Iranian Patients with Chronic Hepatitis C Virus Infection

- Heidar Sharafi

- Mehri Nikbin

- Seyed Hoda Alavian

- Bita Behnava

- Seyed Moayed Alavian

44. Knowledge, attitude, and practice of Iranian health sciences students regarding hepatitis B and C virus infections: A national survey

- Hamidreza Karimi-Sari

- Mohammad Ehsan Bayatpoor

- Maryam Aftabi Khotbesara

- Motahare Sadat Ebrahimi

- Zahra Sattari

- Paria Sattari

- Narges Saberi Shakib

- Hanie Taheri

- Sina Abdolrahim Poor Heravi

- Mahsa Dinizadeh

- Pedram Vahed

- Kiyana Shirsavar

- Hediye Hosseini

- Sara Rashvand

- Dorsa Jalaei

- Mahdi Azarafraz

- Mohebullah Naderi

- Mahtab Pourzakaria

- Mohammad Firoozbakht

- Mohammad Hossein Khosravi

- Seyed Moayed Alavian

45. The Effectiveness of Sofosbuvir and Daclatasvir in the Treatment of Hepatitis C in Thalassaemia Major Patients and their Effect on Haematological Factors

- Farhad Zamani

- Hossein Ajdarkosh

- Fahimeh Safarnezhad-Tameshkel

- Azita Azarkeivan

- Hossein Keyvani

- Farshad Naserifar

- Jamshid Vafaeimanesh

46. Increasing the Awareness of the General Population: An Important Step in Elimination Programs of Viral Hepatitis

- Hamidreza Karimi-Sari

- Maryam Tajik

- Mohammad Ehsan Bayatpoor

- Seyed Moayed Alavian

47. Comment on ‘Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study’

- Seyed M. Alavian

- Heidar Sharafi

48. Antivirales de acción directa contra la hepatitis C: revisión narrativa

- Laura Cristina Gómez-Moreno

- Samuel David García-Vega

- Anlly Paola Pineda-García

- María Adelaida Lopera-Baena

- Andrés Fernando Rodríguez-Gutiérrez

49. Viral hepatitis elimination should receive more attention from Iranian nurses

- Mohammad E. Bayatpoor

- Hamidreza Karimi‐Sari

- Seyed M. Alavian

50. The Effectiveness of Ledipasvir/Sofosbuvir in Youth With Genotype 4 Hepatitis C Virus

- Hanan Mina Fouad

- Amal Ahmed Mohamed

- Magda Sabry

- Hossam Abdel Aziz

- Basem Eysa

- Mohamed Rabea

51. Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China

- Ying Yang

- Feng-Ping Wu

- Wen-Jun Wang

- Juan-Juan Shi

- Ya-Ping Li

- Xin Zhang

- Shang-Suo Dang

52. Street and labour children; special group for elimination of viral hepatitis in Iran

- Hamidreza Karimi-Sari

- Mohammad Saeid Rezaee-Zavareh

- Seyed Moayed Alavian

53. The Middle East and hepatitis C virus infection: does it need special attention?

- Seyed Moayed Alavian

- Mohammad Saeid Rezaee-Zavareh

54. Hepatitis C screening in patients with oral lichen planus

- Hamidreza Karimi‐Sari

- Zahra Ghafari

- Seyed M. Alavian

55. Seroprevalence of Hepatitis C Virus among Blood Donors in Middle Eastern Countries: A Systematic Review and Meta-Analysis

- Hossein Ghaderi-Zefrehi

- Heidar Sharafi

- Farzin Sadeghi

- Mohammad Gholami-Fesharaki

- Alireza Farasat

- Fatemeh Jahanpeyma

- Seyed Moayed Alavian

56. Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C−infected patients with thalassemia

- Arezoo Khosravi

- Hamidreza Karimi‐Sari

- Mahdi Abedi‐Andani

- Bita Behnava

- Ali Namvar

- Ali Anvar

- Seyed Moayed Alavian